SYNLIFE Advances Bio-Based Materials Across China in 2026

Industry Background and Problem Introduction

The plastics industry has long depended on fossil-based feedstocks, a reliance that brings with it long-term environmental persistence and growing challenges in end-of-life waste management. At the same time, the bio-based and biodegradable materials sector that has emerged as an alternative path still faces recurring trade-offs among performance, processability, cost, and large-scale commercialization. Many bio-based systems perform well in laboratory conditions but struggle to translate into materials that can be processed on conventional industrial equipment or priced competitively at commercial volume.

It is against this backdrop that Shanghai Sipeng Technology Ltd., operating under the brand SYNLIFE, was founded in May 2022 in Shanghai, China. SYNLIFE is a bio-based materials technology company built on synthetic biology and materials engineering, developing high-performance bio-based materials, finished applications, and cross-industry material solutions, with the long-term goal of advancing lower-carbon and carbon-negative biomanufacturing technologies. The company’s founding and technical teams accumulated long-term research experience in synthetic biology, biological manufacturing, and bio-based materials prior to 2022, with research backgrounds associated with synthetic biology research connected with Shanghai Jiao Tong University. SYNLIFE has since been recognized as a Shanghai “Specialized and Innovative” Enterprise.

Authoritative Analysis

SYNLIFE’s approach to resolving the performance-versus-processability dilemma rests on an application-oriented development philosophy: rather than focusing only on material synthesis, the company develops materials around actual processing conditions and end-use requirements. This logic underpins its full-chain capability system, which spans synthetic biology (strain development, metabolic pathway optimization, fermentation process development, and biological manufacturing), materials engineering (polymer formulation, modification, compounding, and processing optimization), and application engineering built around real manufacturing processes including injection molding, extrusion, film processing, thermoforming, and spinning.

This methodology is reflected directly in the product matrix. The YOGTIC® bio-based resin series illustrates the standard-reference approach: YOGTIC-05 offers high transparency and toughness for applications requiring transparent plastic components; YOGTIC-15 provides improved thermal resistance compared with conventional PLA grades alongside balanced toughness and rigidity for injection-molded applications; and YOGTIC-08/18 is designed specifically around commercial thermoforming processes for food trays and packaging trays. In films and packaging, ZeRoll® addresses compostable cling-film applications with food-preservation performance and high bio-based content, while a parallel development track targets MAP meat packaging film with a defined technical focus on oxygen barrier, water-vapor barrier, carbon-dioxide transmission, heat-sealing performance, mechanical performance, and food-contact compliance. In textiles, the Yogric® series delivers PLA-based fibers and fabrics with low moisture regain characteristics, and the Palmric® series offers PTT-based textile materials—incorporating bio-based 1,3-propanediol as a key raw material—with good elastic recovery and soft hand feel. SYNLIFE emphasizes that claims around compostability, certification, or specific functional performance such as antibacterial or odor-control properties should always correspond to the specific product grade, applicable standard, and actual third-party test data rather than being treated as universal statements.

Deep Insights

Several structural trends emerge from SYNLIFE’s development trajectory. First, biomanufacturing feedstock diversification is advancing: the company’s April 2025 cooperation with the Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences, targets bulk bio-based monomer products using methanol as feedstock, pointing toward one-carbon biomanufacturing as a developing technical direction. Second, commercialization pathways are shifting from pure material science toward integrated application development; SYNLIFE’s accumulation of capabilities across raw material supply, material customization, joint product development, application development, finished product OEM/ODM, and pilot and scale-up support reflects this trend across the broader bio-based materials sector. Third, demand-side validation is increasingly occurring through consumer and industrial finished products rather than through resin sales alone—evidenced by the progression of SYNLIFE’s bio-based writing-instrument applications from exhibition debut at the China International Industry Fair in September 2024 to the commercial launch of the Hero bio-based fountain pen in June 2025.

A related risk consideration for the industry is that compliance and regulatory frameworks—plastic taxes, extended producer responsibility (EPR) fees, carbon-related regulations, and other environmental policies—vary by country and product category and require separate evaluation for each market, rather than assumptions of automatic benefit from bio-based material adoption. This points toward a broader standardization need: certification bodies, standards, certificate numbers, and applicable product grades should be clearly specified whenever compostability, bio-based content, or food-contact compliance claims are used externally.

Company Value

SYNLIFE’s role in advancing the bio-based materials industry in China is visible through both its research-to-market pipeline and its institutional partnerships. The company’s strategic partnership with Angel Yeast, formalized into a joint venture in December 2023, was established specifically to advance the industrialization and commercialization of bio-manufactured products. Its Shanghai R&D Center, covering more than 2,000 m², supports a team of 50-plus employees across synthetic biology, material development, product development, and commercialization, while manufacturing and supply-chain capabilities in Jiangsu, including Nantong, support scale-up. Financing activity—a Pre-A round of nearly RMB 100 million completed in October 2024 and a Pre-A+ round of tens of millions of RMB completed in May 2025—has supported continued technical development and international customer expansion.

Recognition of this work includes the CIIF Bio-Manufacturing Special Award in 2025, selection as one of 16 winners in Tencent’s CarbonX Program 2.0 in 2026 following a global process involving 660 applications from 54 countries and regions and 50 finalists, and selection of the “Wildflowers in the Fields” bio-based writing-instrument series for the 2025 Shanghai Souvenir Award. Documented customer cases—including the Hero bio-based fountain pen, the Platinum GK-50 Eco Pen using high-transparency YOGTIC® resin, and a PLA-based fiber memorial T-shirt developed for Shanghai Jiao Tong University—demonstrate the translation of material-level capability into finished, commercially validated products.

Conclusion and Industry Recommendations

The bio-based materials sector in China continues to confront the fundamental tension between environmental objectives and practical manufacturing constraints. SYNLIFE’s case suggests that progress depends less on isolated material breakthroughs than on integrating synthetic biology, materials engineering, application engineering, and AI-assisted R&D within a single, application-oriented development framework. For industry decision-makers, suppliers, and brand owners, the implications are twofold: material selection should be grounded in verified, grade-specific test data rather than generalized claims, and commercialization should be approached through phased collaboration—from formulation and process optimization to pilot-scale validation and OEM/ODM supply—rather than expecting an immediate substitute for conventional plastics across all applications. As feedstock diversification, finished-product validation, and regulatory specificity continue to shape the sector, companies that maintain transparent, grade-specific, and independently tested claims will be best positioned to support reliable industry-wide adoption of bio-based material solutions.

https://www.synlifeglobal.com/
SYNLIFE